Investigation of Metformin for the Prevention of Progression of Precursor Multiple Myeloma
Summary
Third Opinion Trial Synopsis:
This research wants to find out if a drug called metformin can help stop a disease called multiple myeloma. They are testing the drug on people with other similar diseases to see if it can prevent multiple myeloma from developing. They are also giving some people a fake pill with no medicine in it called a placebo.
This research wants to find out if a drug called metformin can help stop a disease called multiple myeloma. They are testing the drug on people with other similar diseases to see if it can prevent multiple myeloma from developing. They are also giving some people a fake pill with no medicine in it called a placebo.
*Third Opinion AI Generated Synopsis
Trial Summary
The purpose of this research is to understand whether the drug metformin could be used in the future to help prevent patients with monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM) from developing multiple myeloma. The names of the study drug involved in this study is: Metformin, extended release Placebo ( a pill that has no active ingredients)
The purpose of this research is to understand whether the drug metformin could be used in the future to help prevent patients with monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM) from developing multiple myeloma. The names of the study drug involved in this study is: Metformin, extended release Placebo ( a pill that has no active ingredients)
Locations & Contact
Fill out the form and "Notify Multiple Myeloma Research Foundation" to let the Multiple Myeloma Research Foundation know you are interested in this trial.
Contacts: